Federation Des Caisses Desjardins Du Quebec Dyne Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 20 shares of DYN stock, worth $198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$198
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$79.5 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$73.1 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$66.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$63.2 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $513M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...